J & J's Stelara shows promise against lupus in study

(Reuters) - Johnson& Johnson's blockbuster psoriasis drug Stelara led to a significant reduction in disease activity in patients with systemic lupus compared with a placebo in a midstage clinical trial, according to data released on Saturday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news